Phio Pharmaceuticals Corp (PHIO) Return on equity 2016–2020
Phio Pharmaceuticals Corp (PHIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.6%FY2020 · since FY2016: -82.9% → -67.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -67.6% | +87.4 pp |
| FY2019 | -155.0% | -100.8 pp |
| FY2018 | -54.2% | +625.1 pp |
| FY2017 | -679.3% | -596.5 pp |
| FY2016 | -82.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice